Concise and efficient total syntheses of (±)-sarcophytols A and B, two antitumor cembrane diterpenoids, by an intramolecular Mcmurry olefination strategy

Tetrahedron Letters

Volumn 40, Issue 5, 1999, Pages 965-968

  Li, Wei Dong Z ^a   Li, Ying ^a   Li, Yulin ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DITERPENOID; SARCOPHYTOL A; SARCOPHYTOL B;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CANCER PREVENTION; DRUG ISOLATION; DRUG SYNTHESIS; MARINE ENVIRONMENT; TUMOR;

ALCYONACEA; ANTHOZOA;

EID: 0033613741     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)02574-X     Document Type: Article

References (41)

1. Tursch, B.; Braeckman, J. C.; Dolaze, D.; Kaisin, M. In Marine Natural Products: Chemical and Biological Perspectives; Scheuer, P. J., Ed.; Vol. II, p. 247; Academic: New York, 1978.
2. (a) Tius, M. A. Chem. Rev. 1988, 88, 719;
3. (b) Cox, N. J. G.; Mills, S. D.; Pattenden, G. J. Chem. Soc., Perkin Trans I 1992, 1313 and references cited therein.
4. Kobayashi, M.; Nakagawa, T.; Mitsuhashi, H. Chem. Pharm. Bull. 1979, 27, 2382.
5. (a) Japanese patent 81 61317 and 81 61318 to Mitsubishi Kasei Corporation; Chem. Abstr. 1981, 95, 169547 and 169548;
6. (a) Japanese patent 81 61317 and 81 61318 to Mitsubishi Kasei Corporation; Chem. Abstr. 1981, 95, 169547 and 169548;
7. (b) Fijiki, H.; Saganuma, M.; Takagi, K.; et al. In Anticarcinog. Radiat. Prot. 2, [Proc. Int. Conf.], 1989, 3rd, 357; Nygaard, O. F.; Upton, A. C., Ed.; Plenum: New York, 1991; Chem. Abstr. 1992, 117, 184363.
8. (b) Fijiki, H.; Saganuma, M.; Takagi, K.; et al. In Anticarcinog. Radiat. Prot. 2, [Proc. Int. Conf.], 1989, 3rd, 357; Nygaard, O. F.; Upton, A. C., Ed.; Plenum: New York, 1991; Chem. Abstr. 1992, 117, 184363.
9. (b) Fijiki, H.; Saganuma, M.; Takagi, K.; et al. In Anticarcinog. Radiat. Prot. 2, [Proc. Int. Conf.], 1989, 3rd, 357; Nygaard, O. F.; Upton, A. C., Ed.; Plenum: New York, 1991; Chem. Abstr. 1992, 117, 184363.
10. (a) Fujiki, H.; Sugimura, T. Cancer Serveys 1983, 2, 539;
11. (b) Suganuma, M.; Okabe, S.; Sueoka, E.; Iida, N.; Komoti, A.; Kim, S.-J.; Fujiki, H. Cancer Res. 1996, 56, 3711.
12. For the synthetic studies on sarcophytol A, see: (a)Zou, X.-L; Ph D. Thesis, University of Hawaii, 1995;
13. (b) Takeda, K.; Nakajima, A.; Yoshii, E. Synlett 1995, 249;
14. (c) Takayanagi, H.; Sugiyama, S.; Morinaka, Y. J. Chem. Soc., Perkin Trans I 1995, 751;
15. (d) Takayanagi, H.; Kitano, Y.; Morinaka, Y. J. Org. Chem. 1994, 59, 2700;
16. (e) Li, W.-D.; Mao, J.-M.; Li, Y.; Li, Y.-L. Org. Prep. Proc. Int. 1994, 26, 445;
17. (f) Kodama, M.; Yoshio, S.; Yamaguchi, S.; Fukuyama, Y.; Takayanagi, H.; Morikawa, Y.; Usui, S.; Fukazawa, Y. Tetrahedron Lett. 1993, 34, 8453;
18. (g) Takahashi, T.; Yokoyama, H.; Haino, T.; Yamada, H. J. Org. Chem. 1992, 57, 3521;
19. (h) Takayanagi, H.; Kitano, Y.; Morinaka, Y. Tetrahedron Lett. 1990, 31, 3317;
20. (i) Kodama, M.; Fukuzumi, K.; Kumano, M. Chem. Pharm. Bull. 1989, 37, 1691;
21. (j) Shih, Y.-N.; Ph D. Thesis, Cornell University, 1987.
22. For relative stereochemistry and absolute configuration of sarcophytol B, see: Kobayashi, M.; Iesaka, T.; Nakano, E. Chem. Pharm. Bull. 1989, 37, 2053; for the synthetic studies on sarcophytol B, see: (a) McMurry, J. E.; Rico, J. G.; Shih, Y.-N.; Tetrahedron Lett. 1989, 30, 1173;
23. For relative stereochemistry and absolute configuration of sarcophytol B, see: Kobayashi, M.; Iesaka, T.; Nakano, E. Chem. Pharm. Bull. 1989, 37, 2053; for the synthetic studies on sarcophytol B, see: (a) McMurry, J. E.; Rico, J. G.; Shih, Y.-N.; Tetrahedron Lett. 1989, 30, 1173;
24. (b) Li, Y.; Li, Y.-L. Gaodeng Xuexiao Huaxue Xuebao (Ch.) 1990, 11, 1218; Chem. Abstr. 1991, 114, 164550.
25. (b) Li, Y.; Li, Y.-L. Gaodeng Xuexiao Huaxue Xuebao (Ch.) 1990, 11, 1218; Chem. Abstr. 1991, 114, 164550.
26. Furstner, A.; Bogdanovic, B. Angew. Chem., Int. Ed. Engl. 1996, 35, 2442 and references cited therein.
27. For general reviews, see: (a) McMurry, J. E. Chem. Rev. 1989, 89, 1513;
28. (b) Lenoir, D. Synthesis 1989, 883;
29. (c) McMurry, J. E. Acc. Chem. Res. 1983, 16, 405.
30. Li, Y -L.; Li, W.-D.; Li, Y. J. Chem. Soc., Perkin Trans I 1993, 2953.
31. Corey, E. J.; Pyne, S. G.; Su, W.-G. Tetrahedron Lett. 1983, 24, 4883.
32. 13 by silylation(TBSCI, imidazole, DMF, 23 °C, 100%).
33. Guette, J. P.; Spassky, N.; Boucherot, D. Bull. Soc. Chim. France 1972, 4217.
34. +, 1%).
35. Authentic sample was not available for direct comparsion.
36. 1H NMR spectra according to Allevi, P.; Cajone, F.; Ciuffreda, P.; Anastasia, M. Tetrahedron Lett. 1995, 36, 1347.
37. For example, see: Heathcock, C. H.; Pirrung, M. C.; Young, S. D.; Hagen, J. P.; Jarvi, E. T.; Badertscher, U.; Marki, H.-P.; Montgomery, S. H. J. Am. Chem. Soc. 1984, 106, 8161.
38. For examples, see: (a) Lee, A. W. M.; Martin, V. S.; Masamune, S.; Sharpless, K. B.; Walker, F. J. J. Am. Chem. Soc. 1982, 104, 3515;
39. (b) Lee, A. W. M. Magnetic Resonance in Chemistry 1985, 23, 468.
40. Kobayashi, M.; Osabe, K. Chem. Pharm. Bull. 1989, 37, 631.
41. Financial support of this work was provided by the National Science Foundation of China (No. 29672015).